Table 2.
Summary of the pathological effects and target genes of dysregulated exosomal miRNAs in CNS diseases. The confirmed and putative targets of differentially expressed exosomal miRNAs in specific CNS diseases were listed. Exosomal miRNAs with confirmed pathological effects by perturbation of function approaches were asterisked.
| Disease | miRNA | Targets | Effects of miRNA dysregulation | References |
|---|---|---|---|---|
| Alzheimer’s disease | miR-193b | APP | Promoting Aβ accumulation | Liu et al. (2014) |
| miR-15, miR-107 | CDK5, p35 | Elevating Tau and APP phosphorylation levels | Moncini et al. (2017) | |
| APP, BACE1 | Enhancing APP expression and Aβ accumulation | Parsi et al. (2015) | ||
| miR-342–3p, miR-185–5p | LRP8, APPB2 | Mediating ApoE uptake and APP localization | Jaeger and Pietrzik (2008), Li et al. (2005) | |
| miR-3613–3p | II-1β | Initiating and promoting neuroinflammation | Lugli et al. (2015) | |
| Parkinson’s disease | miR-19b | PARK2/PARK8 | Dysregulating neuronal apoptosis and regeneration | Cao et al. (2017) |
| miR-195, miR-24 | PARK9 | |||
| miR-409–3p | CREB1 | Repressing neuronal genes and neurotrophic factors expression | Gui et al. (2015) | |
| Multiple Sclerosis | miR-196 | IGF2BP1 | Interrupting IGF pathway | Rebucci et al. (2015) |
| let-7i* | IGF1R, TGFBR1 | Inhibiting IGF1R/TGFBR1 expression on CD4+ T cells | Kimura et al. (2018) | |
| Frizzled4 | Modulating the Wnt/beta-catenin pathway | Cai et al. (2017), Jin et al. (2016) | ||
| miR-122 | Wnt | Repressing Wnt signaling | Wang et al. (2014a,b) | |
| miR-23a, miR-146a | CD47 | Releasing macrophages from inhibitory control | Junker et al. (2009) | |
| miR-126 | PIK3R2 | Deactivating anti-apoptotic PI3K/Akt pathway | Chen et al. (2015) | |
| Stroke | miR-125b-2–3p | Eglnl | Enhancing VEGF and reducing cytokine expression | Li et al. (2016) |
| miR-21, miR-126, miR-33, | PTEN, Bcl-2, VCAM1, | Upregulating VCAM1 expression, enhancing leukocyte | Rink and Khanna (2011) | |
| miR-125a-5p, miR-155, | OSBP-9, AT1R, | adherence to the endothelium, decrease endothelial cell | ||
| miR-222, miR-210 | STAT5a | proliferation and migration | ||
| Glioblastoma | miR-21 | RECK, TIMP3 | Promotes Glioma Invasion | Gabriely et al. (2008) |
| miR-21 | PTEN, FOXO1, EGFR | Decreasing Bax/Bcl-12 ratio and inhibiting activity of caspase3/9 | Lei et al. (2014), Shi et al. (2010), Tokudome et al. (2015), Zhou et al. (2010) | |
| miR-301 | PTEN | Activating the AKT and FAK signaling pathways | Lan et al. (2018) | |
| miR-373 | CD44, TGFBR2 | Inhibiting cell migration and invasion | Wei et al., 2016 | |
| miR-25, miR-92a | p21, Bim | Modulating cell cycle process | Kan et al. (2009), Wong et al. (2010) | |
| Metastasis | miR-122 | PKM | Repressing glucose consumption in niche cells | Fong et al. (2015) |
| miR-19a | PTEN | Enhance tumor cell proliferation and survival | Zhang etal. (2015) |